We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer

News   Apr 30, 2008

 
Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer
 
 
 

RELATED ARTICLES

Increasing Food Intake by Swapping Mitochondrial Genomes

News

To uncover the relationship between variation in genes and phenotypic diversity, geneticists use a set of fully sequenced fruit-fly genomes. But little is known about the variation in the mitochondrial genome, for which mutations are linked to an array of diseases. Now, EPFL scientists have created a high-resolution map of mitochondrial DNA variants in the fruit fly, connecting mitochondrial genes to metabolic traits and diseases.

READ MORE

Geneticists Identify Hundreds of Small Metabolites That Are Potential Disease Indicators

News

New research has identified hundreds of metabolites that could one day help doctors better monitor metabolite variation as an indicator of disease.

READ MORE

Targeting a Protease To Treat Inflammatory Bowel Disease

News

The protease MT1-MMP could be a possible future target for drugs to treat inflammatory bowel disease (IBD) according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE